PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Transmitted Drug Resistance To Integrase Based First-Line HIV Antiretroviral Treatment In The MeditRes HIV CollaborationView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina CohortView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 IsolatesView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Residual Phenotypic Susceptibility To Second Generation Nnrti In Multidrug Resistant HIV-1 From The Prestigio RegistryView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Unexpected Rising In The Circulation Of Complex HBV Variants Enriched Of HBsAg Vaccine-Escape Mutations In HBV Genotype-D: Potential Impact On HBsAg Detection/Quantification And Vaccination StrategiesView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020A Changing Of HIV-1 Genetic Diversity In Russia During The Last Two Decades: Increase Of The Recombinants PrevalenceView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary InfectionView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Molecular Epidemiology Of The HIV-1 Infection In Cyprus (2017-2019): A Polyphyletic Infection With An Increasing Prevalence Of Drug ResistanceView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or DurabilityView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed PatientsView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In NorwayView Poster
PosterHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWHView Poster
